Tilfælde af osteonekrose (primært i kæberne) er blevet rapporteret, overvejende hos cancerpatienter i behandling med bisfosfonater, herunder Zometa.
Cases of osteonecrosis (primarily of the jaws) have been reported, predominantly in cancer patients treated with bisphosphonates, including Zometa.